LivaNova ( (LIVN) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
LivaNova’s stock has gained positive momentum following the announcement of a substantial increase in Medicare reimbursement rates for their VNS Therapy, set to take effect in 2026. This news has prompted analysts to raise their price targets for the company, highlighting strategic growth plans and the potential commercialization of their OSA device as significant factors. Additionally, LivaNova’s introduction of 2030 financial targets and expectations for the OSA business to break even by 2029 have further bolstered investor confidence.
More about LivaNova
YTD Price Performance: 18.52%
Average Trading Volume: 556,295
Technical Sentiment Signal: Buy
Current Market Cap: $3.02B
For further insights into LIVN stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.